Tag: Almirall

June 25, 2019 Off

Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis

By BusinessWire

Dermira set to receive an option exercise fee of $50 million and additional potential milestone payments and royalties

October 27, 2015 Off

Allergan Acquires Rights To Ironwood’s Constella

By Dino Mustafić

Allergan plc and Ironwood Pharmaceuticals, Inc. have announced that Allergan has acquired rights to Constella (linaclotide) in the European Union, Switzerland, Turkey and the Commonwealth of Independent States from Almirall, S.A. and has also reacquired rights to Linzess (linaclotide) in Mexico from Almirall.